HSIC

HENRY SCHEIN INC

13 filings tracked

healthcarehealthcare distributionMID ($2B-10B)

Signal Magnitude Chart

bullish

bearish

neutral

Signal Timeline

bullishMay 22

Appointment of an Independent Chairman to improve board oversight.

management change

70%

neutralMay 22

Shareholder approval of 'govern by majority vote' proposal.

regulatory action

30%

bullishMay 22

Appointment of an Independent Chairman to improve board oversight.

management change

70%

neutralMay 22

Shareholder approval of 'govern by majority vote' proposal.

regulatory action

30%

bullishMay 22

Appointment of an Independent Chairman to improve board oversight.

management change

70%

neutralMay 22

Shareholder approval of 'govern by majority vote' proposal.

regulatory action

30%

bullishMay 22

Appointment of an Independent Chairman to improve board oversight.

management change

70%

neutralMay 22

Shareholder approval of 'govern by majority vote' proposal.

regulatory action

30%

bullishMay 22

Appointment of an Independent Chairman to improve board oversight.

management change

70%

neutralMay 22

Shareholder approval of 'govern by majority vote' proposal.

regulatory action

30%

bullishMay 22

Appointment of an Independent Chairman to improve board oversight.

management change

70%

neutralMay 22

Shareholder approval of 'govern by majority vote' proposal.

regulatory action

30%

bullishMay 5

Net sales grew 6.3% to $3.37 billion, driven by strong dental demand.

earnings beat

60%

bullishMay 5

Overall gross margin improved to 31.8% due to a shift toward high-margin specialty and tech products.

margin expansion

40%

bullishMay 5

Aggressive share repurchases reduced share count, boosting diluted EPS to $0.92.

buyback

70%

bearishMay 5

Total debt increased by over $300 million, increasing reliance on revolving credit lines.

debt restructure

50%

bullishMay 5

Net sales grew 6.3% to $3.37 billion, driven by strong dental demand.

earnings beat

60%

bullishMay 5

Overall gross margin improved to 31.8% due to a shift toward high-margin specialty and tech products.

margin expansion

40%

bullishMay 5

Aggressive share repurchases reduced share count, boosting diluted EPS to $0.92.

buyback

70%

bearishMay 5

Total debt increased by over $300 million, increasing reliance on revolving credit lines.

debt restructure

50%

bullishMay 5

Net sales grew 6.3% to $3.37 billion, driven by strong dental demand.

earnings beat

60%

bullishMay 5

Overall gross margin improved to 31.8% due to a shift toward high-margin specialty and tech products.

margin expansion

40%

bullishMay 5

Aggressive share repurchases reduced share count, boosting diluted EPS to $0.92.

buyback

70%

bearishMay 5

Total debt increased by over $300 million, increasing reliance on revolving credit lines.

debt restructure

50%

bullishMay 5

Net sales grew 6.3% to $3.37 billion, driven by strong dental demand.

earnings beat

60%

bullishMay 5

Overall gross margin improved to 31.8% due to a shift toward high-margin specialty and tech products.

margin expansion

40%

bullishMay 5

Aggressive share repurchases reduced share count, boosting diluted EPS to $0.92.

buyback

70%

bearishMay 5

Total debt increased by over $300 million, increasing reliance on revolving credit lines.

debt restructure

50%

bullishMay 5

Net sales grew 6.3% to $3.37 billion, driven by strong dental demand.

earnings beat

60%

bullishMay 5

Overall gross margin improved to 31.8% due to a shift toward high-margin specialty and tech products.

margin expansion

40%

bullishMay 5

Aggressive share repurchases reduced share count, boosting diluted EPS to $0.92.

buyback

70%

bearishMay 5

Total debt increased by over $300 million, increasing reliance on revolving credit lines.

debt restructure

50%

bullishMay 5

Net sales grew 6.3% to $3.37 billion, driven by strong dental demand.

earnings beat

60%

bullishMay 5

Overall gross margin improved to 31.8% due to a shift toward high-margin specialty and tech products.

margin expansion

40%

bullishMay 5

Aggressive share repurchases reduced share count, boosting diluted EPS to $0.92.

buyback

70%

bearishMay 5

Total debt increased by over $300 million, increasing reliance on revolving credit lines.

debt restructure

50%

bullishMay 5

Net sales grew 6.3% to $3.37 billion, driven by strong dental demand.

earnings beat

60%

bullishMay 5

Overall gross margin improved to 31.8% due to a shift toward high-margin specialty and tech products.

margin expansion

40%

bullishMay 5

Aggressive share repurchases reduced share count, boosting diluted EPS to $0.92.

buyback

70%

bearishMay 5

Total debt increased by over $300 million, increasing reliance on revolving credit lines.

debt restructure

50%

Filing History

8-KMay 22, 2026

The recent 8-K filing details the results of Henry Schein's 2026 Annual Meeting and the subsequent appointment of an Independent Chairman. While the board successfully navigated the election of its incumbents and the ratification of its auditors, the narrow victory on the 'govern by majority vote' proposal and the volume of dissenting votes highlight an uneasy relationship with some shareholders. The market's reaction will likely depend on whether the new leadership can translate this governance shift into tangible operational improvements and improved shareholder returns.

10-QMay 5, 2026

The Q1 2026 filing reveals a company at a critical crossroads, balancing aggressive growth and strategic transformation against deteriorating liquidity. On one hand, the top-line growth and the shift toward high-margin technology and specialty products suggest a viable path toward a more profitable business model. The institutional backing from KKR and the leadership change provide a catalyst for the 'One Schein' vision to materialize. However, the disconnect between reported net income and actual cash flow is the primary risk factor. The ability to sustain the current pace of share repurchases and acquisitions while managing a growing debt load will depend on the company's ability to convert its accounting profits into operating cash. Investors must weigh the long-term secular tailwinds of an aging population against the immediate pressure of working capital inefficiency and rising interest costs.